RETA (GLP-3)

RETA (GLP-3) 10 MG

1. Description: RETA, chemically known as Retatrutide, is a novel synthetic peptide that functions as a triple hormone receptor agonist. Unlike single or dual agonists, this compound is designed to simultaneously target and activate the Glucagon-Like Peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and Glucagon (GCGR) receptors. Research focuses on its unique mechanism of action involving the regulation of glucose metabolism and energy expenditure through multiple physiological pathways.

2. Specifications:

• Sequence: Triple Agonist (GLP-1 / GIP / Glucagon Receptor)

• Molecular Formula: C223​H343​N65​O64​

• Molecular Weight: ~4731.33 g/mol

• Purity: ≥ 99% (Verified by Certificate of Analysis)

3. Application Context: In laboratory environments, RETA (GLP-3) is utilized to investigate advanced metabolic regulation. Key areas of study include:

• Analyzing the synergistic effects of triple receptor activation on lipid metabolism and hepatic clearance.

• Investigating mechanisms related to energy homeostasis and thermogenesis (calorie expenditure) in non-clinical models.

• Studying the comparative efficacy of triple agonists versus mono-agonists on glycemic control and insulin sensitivity.

4. Intended Use: This compound is intended strictly for in vitro laboratory research. It is not approved for human or animal use and must not be incorporated into food, drugs, cosmetics, or diagnostic products.

5. Legal Disclaimer: This product and associated materials have not been evaluated by the FDA. No claims are made regarding diagnosis, treatment, or prevention of disease. Use is restricted to qualified research professionals in certified laboratory settings.